Lisa Ann Marie Fleshman, Ms
About Lisa Ann Marie Fleshman, Ms
Lisa Ann Marie Fleshman serves as the Vice President of Quality and Compliance, where she partners with leadership to enhance service and product quality. With extensive experience in quality assurance and compliance across various organizations, she employs a risk-based strategy to prioritize operations and ensure compliance excellence.
Current Role at Sanguine
Lisa Ann Marie Fleshman serves as the Vice President of Quality and Compliance at Sanguine. In this role, she partners with leadership to enhance service and product quality across various departments. She has been in this position since 2024, focusing on implementing a risk-based strategy to prioritize operations within the Quality Compliance Office. Her responsibilities include collecting and analyzing performance metrics to identify trends and risks, as well as reviewing the effectiveness of key performance indicators (KPIs) to achieve quality outcomes.
Previous Experience at Sanguine
Prior to her current role, Fleshman held multiple positions at Sanguine. She served as the Executive Director of Quality and Compliance from 2023 to 2024, and as the Associate Director of GCP & GxP Quality Assurance and Compliance from 2021 to 2022. In these roles, she provided leadership in quality assurance activities and developed strategies for compliance within the organization. Her tenure at Sanguine has contributed to her extensive knowledge in quality management and compliance.
Professional Background in Quality Assurance
Fleshman has a comprehensive background in quality assurance within the pharmaceutical industry. She worked as a Quality Assurance Specialist III at MilliporeSigma from 2018 to 2020 and as a Quality Assurance Manager at Precision For Medicine from 2020 to 2021. Additionally, she held roles at BioTelemetry, Inc. and Covance, where she focused on regulatory compliance and quality assurance. This diverse experience has equipped her with the skills necessary to lead quality initiatives effectively.
Educational Qualifications
Fleshman holds a Bachelor of Science degree in Biology and Environmental Science from Mount St. Mary's University, where she studied from 2006 to 2010. She furthered her education by obtaining a Master's degree in Environmental and Risk Management from the University of Maryland Global Campus between 2011 and 2013. Her educational background supports her expertise in quality compliance and risk management in the pharmaceutical sector.
Expertise in Compliance and Quality Procedures
Fleshman has developed expertise in implementing compliance and quality procedures associated with various regulatory frameworks, including CFR Part 11, 45, 46, and 50. She leads efforts to ensure compliance excellence and audit readiness by assessing compliance gaps relative to client and regulatory requirements. Her strategic development of GxP Quality Assurance activities has been instrumental in maintaining high standards within her organization.